Table 4 |
|||
|
Vif/Vpr and Gag sequences containing G-to-A mutations that resulted in Stop/Start codon mutations, other mutations, or no mutations. |
|||
|
Sample |
Total Sequences with Stop/Start Codon Mutations (%) |
Total Sequences w/ Other Mutations (%) |
Total Sequences w/ No Mutations (%) |
|
|
|||
|
Vif/Vpr |
|||
|
DNA (Round 2 +3) |
83 (59.7%) |
30 (21.6%) |
26 (18.2%) |
|
Cellular Viral RNA (Round 2+3) |
24 (22.2%) |
22 (20.4%) |
62 (57.4%) |
|
Virion RNA (Round 2+3) |
13 (10.2%) |
16 (12.6%) |
98 (77.2%) |
|
Gag |
|||
|
DNA (Round 2) |
17 (70.8%) |
2 (8.3%) |
5 (20.8%) |
|
Cellular Viral RNA (Round 2) |
26 (22.4%) |
24 (20.7%) |
66 (56.9%) |
|
Virion RNA (Round 2) |
6 (6.3%) |
12 (12.5%) |
78 (81.3%) |
|
|
|||
|
Russell et al. Retrovirology 2009 6:16 doi:10.1186/1742-4690-6-16 |
|||
